97-2000. Agency Forms Undergoing Paperwork Reduction Act Review  

  • [Federal Register Volume 62, Number 18 (Tuesday, January 28, 1997)]
    [Notices]
    [Pages 4051-4053]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-2000]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    [30DAY-27]
    
    
    Agency Forms Undergoing Paperwork Reduction Act Review
    
        The Centers for Disease Control and Prevention (CDC) publishes a 
    list of information collection requests under review by the Office of 
    Management and Budget (OMB) in compliance with the Paperwork Reduction 
    Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
    the CDC Reports Clearance Office on (404) 639-7090. Send written 
    comments to CDC, Desk Officer; Human Resources and Housing Branch, New 
    Executive Office Building, Room 10235; Washington, DC 20503. Written 
    comments should be received within 30 days of this notice.
        The following requests have been submitted for review since the 
    last publication date on January 16, 1997.
    
    Proposed Projects
    
        1. The National Home and Hospice Care Survey (NHHCS)--(0920-0298)--
    Revision--The National Home and Hospice Care Survey (NHHCS) was 
    conducted in 1992, 1993, 1994 and 1996. It is part of the long-term 
    Care component of the National Health Care Survey. Section 306 of the 
    Public Health Service Act states that the National Center for Health 
    Statistics ``shall collect statistics on health resources * * * [and] 
    utilization of health care, including utilization of * * * services of 
    hospitals, extended care facilities, home health agencies, and other 
    institutions.'' NHHCS data are used to examine this most rapidly 
    expanding sector of the health care industry. Data from the NHHCS are 
    widely used by the health care industry and policy makers for such 
    diverse analyses as the need for various medical supplies; minority 
    access to health care; and planning for the health care needs of the 
    elderly. The NHHCS also reveals detailed information on utilization 
    patterns, as needed to make accurate assessments of the need for and 
    costs associated with such care. Data from earlier NHHCS collections 
    have been used by the Congressional Budget Office, the Bureau of Health 
    Professions, the Maryland Health Resources Planning Commission, the 
    National Association for Home Care, and by several newspapers and 
    journals. Additional uses are expected to be similar to the uses of the 
    National Nursing Home Survey. NHHCS data cover: baseline data on the 
    characteristics of hospices and home health agencies in relation to 
    their patients and staff, Medicare and Medicaid certification, costs to 
    patients, sources of payment, patients'' functional status and 
    diagnoses. Data collection is planned for the period July-October, 
    1997. Survey design is in process now. Sample selection and preparation 
    of layout forms will precede the data collection by several months. The 
    total annual burden is 5,000.
    
    ------------------------------------------------------------------------
                                                                   Average  
                                       Number of    Number of      burden/  
               Respondents            respondents   responses/  response (in
                                                    respondent     hours)   
    ------------------------------------------------------------------------
    Agency Questionnaire............        1,200            1         0.333
    Current Patient Sampling List...        1,200            1          .333
    Current Patient Questionnaire...        1,200            6          .25 
    Discharged Patient Sampling List        1,200            1          .50 
    
    [[Page 4052]]
    
                                                                            
    Discharged Patient Questionnaire        1,200            6          .25 
    ------------------------------------------------------------------------
    
        2. List of Ingredients Added to Tobacco in the Manufacture of 
    Smokeless Tobacco Products--(0920-0338)--Extension--Oral use of 
    smokeless tobacco represents a significant health risk which can cause 
    cancer and a number of noncancerous oral conditions, and can lead to 
    nicotine addiction and dependence. Furthermore, smokeless tobacco use 
    is not a safe substitute for cigarette smoking. The Centers for Disease 
    Control and Prevention's (CDC) Office on Smoking and Health (OSH) has 
    been delegated the authority for implementing major components of the 
    Department of Health and Human Services' (HHS) tobacco and health 
    program, including collection of tobacco ingredients information. HHS's 
    overall goal is to reduce death and disability resulting from cigarette 
    smoking and other forms of tobacco use through programs of information, 
    education and research.
        The Comprehensive Smokeless Tobacco Health Education Act of 1986 
    (15 U.S.C. 4401 et seq., Pub.L. 99-252) requires each person who 
    manufactures, packages, or imports smokeless tobacco products to 
    provide the Secretary of HHS with a list of ingredients added to 
    tobacco in the manufacture of smokeless tobacco products. HHS is 
    authorized to undertake research, and to report to the Congress (as 
    deemed appropriate), on the health effects of the ingredients. The 
    total annual burden is 286.
    
    ------------------------------------------------------------------------
                                                                   Average  
                                        Number of    Number of     burden/  
               Respondents             respondents   responses/    response 
                                                     respondent   (in hours)
    ------------------------------------------------------------------------
    Tobacco manufacturers............           11            1           26
    ------------------------------------------------------------------------
    
        3. List of Ingredients Added to Tobacco in the Manufacture of 
    Cigarette Products--(0920-0210)--Reinstatement--Cigarette smoking is 
    the leading preventable cause of premature death and disability in our 
    nation. Each year more than 400,000 premature deaths occur as the 
    result of cigarette smoking related diseases. The Centers for Disease 
    Control and Prevention (CDC), Office on Smoking and Health has primary 
    responsibility for the Department of Health and Human Services' (HHS) 
    smoking and health program. HHS's overall goal is to reduce death and 
    disability resulting from cigarette smoking and other forms of tobacco 
    use through programs of information, education and research.
        The Comprehensive Smoking Education Act of 1984 (15 U.S.C. 1336 
    Pub.L. 98-474) requires each person who manufactures, packages, or 
    imports cigarettes to provide the Secretary of HHS with a list of 
    ingredients added to tobacco in the manufacture of cigarettes. This 
    legislation also authorizes HHS to undertake research, and to report to 
    the Congress (as deemed appropriate), on the health effects of the 
    ingredients.
        In 1993, OMB reinstated approval for collection of ingredients 
    information (0920-0210) after the expiration of the previous approval; 
    this current approval expired on December 31, 1996. The total annual 
    burden is 2,660.
    
    ------------------------------------------------------------------------
                                                                   Average  
                                          No. of       No. of      burden/  
               Respondents             respondents   responses/    response 
                                                     respondent   (in hours)
    ------------------------------------------------------------------------
    Tobacco Manufacturers............           14            1          190
    ------------------------------------------------------------------------
    
        4. Surveys of State-Based Diabetes Control Cooperative Agreement 
    Programs--New--Diabetes Mellitus and related complications are the 
    seventh leading cause of death in the United States, and accounts for 
    $105 billion in direct medical costs and lost productivity each year. 
    Approximately 14 million Americans have been diagnosed with diabetes, a 
    leading cause of new blindness and end-stage renal failure in the 
    United States and a major co-morbid factor in lower extremity 
    amputation, cardiovascular disease and related death, and neonatal 
    morbidity and mortality.
        Through the support of the Centers for Disease Control and 
    Prevention (CDC) ``State-Based Program to Reduce the Burden of 
    Diabetes: A Health Systems Approach,'' public health departments in 42 
    states and four U.S. territorial affiliated jurisdictions have been 
    charged with providing leadership in reducing the gap between what 
    should be and what is the current standard of diabetes care.
        CDC will collect information from diabetes State Program 
    Coordinators regarding the four key areas of program implementation. 
    They are (1) Capacity building and infrastructure development, (2) 
    surveillance and data collection, (3) health systems change, and (4) 
    working with local programs.
        The survey has three main objectives:
        1. Document the progress made by Diabetes Control Programs in the 
    four main areas of program implementation.
        2. Assess the relationship between the level of infrastructure 
    development, and a program's efforts to carry out surveillance 
    activities, health systems change activities, and work with local 
    programs. Information will help improve technical assistance (TA) and 
    guidance offered to states by CDC.
        3. Lay the groundwork for an evaluation instrument that can be used 
    to collect data from Diabetes Control Programs at the end of the 
    funding cycle in order to assess whether progress in program 
    implementation and development is linked to reduced diabetes morbidity 
    and mortality.
        The data will result from self-administered mailed surveys sent to 
    the Program Coordinator in each state. Most questions will be in the 
    form of
    
    [[Page 4053]]
    
    checklists although each of the four sections contain a number of open-
    ended questions for explanation of unique features of programs. It is 
    expected that the burden in time to each respondent will be about two 
    (2) hours per Program Coordinator or Designee, resulting in a total 
    burden of 92 hours. Results will also be made available to participants 
    upon request. The total annual burden is 84.
    
    ------------------------------------------------------------------------
                                                                   Average  
                                          No. of       No. of       burden  
               Respondents             respondents   responses/    response 
                                                     respondent   (in hours)
    ------------------------------------------------------------------------
    Diabetes Program Coordinators....           42            1            2
    ------------------------------------------------------------------------
    
        Dated: January 22, 1997.
    Wilma G. Johnson,
    Acting Associate Director for Policy Planning and Evaluation, Centers 
    for Disease Control and Prevention (CDC).
    [FR Doc. 97-2000 Filed 1-27-97; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
01/28/1997
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
97-2000
Pages:
4051-4053 (3 pages)
Docket Numbers:
30DAY-27
PDF File:
97-2000.pdf